Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cordlife Group ( (SG:P8A) ) just unveiled an update.
Cordlife Group Limited has received a notice from the Ministry of Health (MOH) regarding the suspension of its cord blood banking service license for one year due to non-compliance with healthcare regulations. The non-compliance issues include deficiencies in quality management, operations continuity, and risk assessment, among others. The suspension and required corrective actions could impact the company’s operations and its position in the healthcare industry.
More about Cordlife Group
Cordlife Group Limited is a company registered in Singapore, operating in the healthcare industry with a focus on cord blood banking services and human tissue banking.
Average Trading Volume: 49,757
Technical Sentiment Signal: Sell
Current Market Cap: S$54.89M
For a thorough assessment of P8A stock, go to TipRanks’ Stock Analysis page.